A report found the VA’s Eastern Area Fiduciary Hub in Indianapolis was “not timely processing allegations of misuse of beneficiary funds, conducting field examinations, and processing some incoming mail.”
Getting everyone into the same room prior to surgeries is cutting costs and improving health.
The 5-year-old firm has pledged to invest $20 million to double the size of its corporate headquarters in Indianapolis and lease real estate for a series of 3,500-square-foot health clinics across the state.
Sanofi will apply for approval of Cialis as an over-the-counter treatment in the United States, Europe, Canada and Australia. The drug garnered $2.16 billion in sales last year.
A judge has sentenced an Indianapolis doctor to 10 years in prison for writing illicit prescriptions for powerful painkillers after the Drug Enforcement Administration had suspended his authority to dispense controlled substances.
U.S. Sen. Joe Donnelly said administrators at Indiana's VA hospitals have told him they don't have the same kind of problems as the 26 veterans facilities across the country facing complaints about long waits and backlogs.
Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry's history.
Two public hearings are scheduled this week on Gov. Mike Pence's plan to use Medicaid funds to expand the Healthy Indiana Plan to provide insurance under the federal health care overhaul.
Takeda Pharmaceutical was found not liable for the bladder cancer of two women who used its Actos diabetes medication in the company’s latest trial over the drug. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.
Takeda Pharmaceutical Co. didn’t hide the alleged bladder-cancer risks of its diabetes medicine Actos, a lawyer for the company told a jury. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.
The health insurance expansion Gov. Mike Pence is touting relies on federal Medicaid money and meets federal Medicaid requirements, but the Republican governor insists it's not Medicaid.
Takeda Pharmaceutical Co. executives covered up the cancer risks of its diabetes medicine Actos to protect billions of dollars in sales, a lawyer for two women argued.
The $30 million project at Columbus Regional Hospital will expand its emergency department and cancer center.
Pfizer’s proposed deal would have been the richest acquisition ever among drugmakers and the third-biggest deal in any industry, according to figures from research firm Dealogic.
Eli Lilly and Co. lost a United Kingdom lawsuit over its Alimta cancer treatment when a judge ruled Thursday that a generic version planned by Actavis Plc doesn’t breach European patents.
Officials with direct knowledge of the plan said participants in the first tier would receive limited coverage at no charge. A second tier would include dental and vision coverage and require participant contributions.
WellPoint Inc. competitor UnitedHealth Group Inc., the largest U.S. health insurer, will lead an industry effort to throw a spotlight on the prices paid for health-care services, making their costs available to consumers on the Internet.
Before the law took effect, experts warned that narrow networks could impact patient's access to care, especially in cheaper plans. But with insurance cards now in hand, consumers are finding their access limited across all price ranges.
Brazilian federal prosecutors had accused a Lilly subsidiary of incinerating toxic waste at the plant that it operated until 2003.
Eli Lilly & Co. said its experimental insulin helped diabetic patients more than Sanofi’s biggest product in studies that also raised some safety risks.
